- Home
- MVIS vs ATYR Comparison
MVIS vs ATYR Comparison
Compare MVIS & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVIS
- ATYR
- Stock Information
- Founded
- MVIS 1993
- ATYR 2005
- Country
- MVIS United States
- ATYR United States
- Employees
- MVIS N/A
- ATYR N/A
- Industry
- MVIS Industrial Machinery/Components
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MVIS Technology
- ATYR Health Care
- Exchange
- MVIS Nasdaq
- ATYR Nasdaq
- Market Cap
- MVIS 272.0M
- ATYR 263.9M
- IPO Year
- MVIS 1996
- ATYR 2015
- Fundamental
- Price
- MVIS $1.17
- ATYR $3.46
- Analyst Decision
- MVIS Buy
- ATYR Strong Buy
- Analyst Count
- MVIS 4
- ATYR 6
- Target Price
- MVIS $2.67
- ATYR $18.60
- AVG Volume (30 Days)
- MVIS 4.6M
- ATYR 1.4M
- Earning Date
- MVIS 05-08-2025
- ATYR 05-01-2025
- Dividend Yield
- MVIS N/A
- ATYR N/A
- EPS Growth
- MVIS N/A
- ATYR N/A
- EPS
- MVIS N/A
- ATYR N/A
- Revenue
- MVIS $4,696,000.00
- ATYR $235,000.00
- Revenue This Year
- MVIS $486.46
- ATYR $551.06
- Revenue Next Year
- MVIS $137.89
- ATYR $2,144.84
- P/E Ratio
- MVIS N/A
- ATYR N/A
- Revenue Growth
- MVIS N/A
- ATYR N/A
- 52 Week Low
- MVIS $0.80
- ATYR $1.42
- 52 Week High
- MVIS $1.95
- ATYR $4.66
- Technical
- Relative Strength Index (RSI)
- MVIS 44.89
- ATYR 59.35
- Support Level
- MVIS $1.07
- ATYR $2.85
- Resistance Level
- MVIS $1.32
- ATYR $3.15
- Average True Range (ATR)
- MVIS 0.11
- ATYR 0.28
- MACD
- MVIS -0.00
- ATYR 0.08
- Stochastic Oscillator
- MVIS 50.00
- ATYR 99.19
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.